DOCSLIB.ORG

Summer 2017 Volume 13 Number 1

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Summer 2017 Volume 13 Number 1 THE MAGAZinE OF THE SCHOOL OF MEDICinE Alumni AssoCiation - UniVERsitY OF UtaH ILLUMINATIONSSummer 2017 Volume 13 Number 1 ASPIRATIONS BY CatHY ManGUM MSIII EDitor Kristin Wann Anderson, MS COMMUnications COMMITTEE Jennifer M. Coombs, PA-C, PhD, Chair Marcia Feldkamp, PA-C, PhD The Magazine for the University of Utah School of Medicine Alumni and Friends Dale Hull, MD Tommy Skidmore, MD Bryan Stone, MD Eric Vanderhooft, MD PHotoGRAPHY CREDits: ILLUMINATIONS Kristan Jacobsen Photography Blythe Stewart Alumni Relations Staff WHat’S InsiDE D1 ean’s Message 2 Executive Director’s Message 3 Bone Marrow Transplant in Brazil: The Utah Connection The 1980s - Pioneering the Impossible Jacqueline Voland, 6 Kristin Wann Anderson and Blythe Stewart Alumni and Community Weekend University of Utah School of Medicine Alumni 11 Association Board of Directors Bryan L. Stone, MD 1986 Event Schedule President Dale B. Hull, MD, MPA, 1985 UTEMED Talks Past President Terry Box, MD, HS 1983 Distinguished Awards Vice President J. Eric Vanderhooft, MD, 1988 18 Student Life Secretary/Treasurer Rubor Submissions Jennifer M. Coombs, PA-C, MPAS, PhD, 2011 Thomas D. Coppin, MD 1967 What Training a Medical Student Really Costs John C. Edwards, MD 1987 Marcia L. Feldkamp, PAC, MPH, PhD, 1986 Match Day Brent C. James, MD, 1978 R. Kent Jex, MD, 1982 Commencement 2017 Karen L. Miller, MD, HS, 1990 Teresa L. Ota, MD, 1988 Dean’s Roundtable Kathy Pedersen, PA-C, MPAS, 2002 Karly Pippitt, MD, 2006 Angelica R. Putnam, MD, 2002 26 News Notebook J. Charles Rich, MD, 1965 Thomas B. Skidmore, MD, 2007 These Mice are Walking: New Discoveries in MS Research Adam Stevenson, MD, 2001 P. Daniel Ward, MD, 2004 36 Alumni Notebook Susan Wiet, MD, HS 2003 John R. Wood, MD, 1977 Back Cover I Know You... or do I? MEDICAL stUDENT Representatives: Appointed in September EX-OFFICIO: A. Lorris Betz, MD, PhD Sr. Vice President Health Sciences, Dean, School of Medicine, LETTERS to THE EDitoR: FoR ADDRESS CHANGES OR to CEO University of Utah Health These will be posted on the SOM OPT OUT OF Illuminations Alumni Web site. Submit letters at Join the University of Utah School of ContaCT: Wayne M. Samuelson, MD [email protected] Medicine Network on LinkedIn [email protected] Interim Dean, School of Medicine Office of Alumni Relations Kristin Wann Anderson, MS VISIT OUR WEB SITE: 515 East 100 South, Suite 300 Executive Director, Alumni Relations, www.medicine.utah.edu/alumni Salt Lake City, Utah 84102 Find us on Facebook School of Medicine Update your information at: 801-585-3818 https://app.medicine.utah.edu/ University of Utah School of Medicine Stephen R. Warner, MBA SOMAlumni/index.htm or email Alumni Association Senior Executive Director, [email protected] Health Sciences Advancement “I always look forward to the excitement of graduation. As I looked out at the faces of our graduating class of 2017, I realized I was witnessing a historic moment. I have never been more certain of the promise the future holds.” Dean’S MessaGE I thought about how this fresh crop of highly continues. We will strive to maintain the momentum capable, well-trained doctors from the University of generated by her transformational leadership. She Utah are following in the footsteps of a long line of expanded our reach in research, health care delivery trailblazers, who were—and still are—compelled to and education. Her influence will be seen and felt come to Utah to be part of a distinctly collaborative for years to come. ecosystem where they are accomplishing things that really can’t be done anywhere else. This remarkable The university has received national recognition for class is blazing new trails of its own. The Class of 2017, providing high-quality and patient-centered care, while now officially joining the ranks of U of U School of stabilizing and reducing costs, securing our ranking as Medicine alumni, will always hold a special place #1 in the nation for quality and the #1 hospital in the in our history as the first expanded class to benefit state. U of U Health was also the first health care system from Senate Bill 42. Passed four years ago, the bill to publish online patient reviews, now more than 30 provided for a phased increase in the medical school health care organizations follow suit. class size, expanding from 82 to 102 students—and ultimately to 125. As illustrated by the stories and news in this issue of Illuminations, our health system, research productivity While it’s true that our world is in transition and and training programs have never been stronger. uncertainty abounds, these students are entering We are grateful to Dr. Lee for her vision and contributions. the profession of medicine at a time of amazing Dr. Betz is committed to carrying them forward. scientific discovery. There will be endless opportunities As we move full speed ahead with the exciting to address problems in the human condition through transformation of our health sciences campus, we advanced technologies. are poised to continue as a leader in health care innovation here and abroad. New facilities will enhance We find ourselves in the midst of an important our ability to provide world-class interdisciplinary transition in leadership. Dr. Vivian Lee has stepped training for our students, providing a holistic approach down from her roles as Senior Vice President for for the best possible patient care. Health Sciences, CEO of University of Utah Health and Dean of the School of Medicine. Dr. A. Lorris Betz has agreed to come out of retirement to lead the Health Sciences on an interim basis. He has asked me to assume the role of interim dean of the School Wayne M. Samuelson, MD of Medicine while the search for Dr. Lee’s successor Interim Dean, School of Medicine 1 “We are only able to assist Executive our students and encourage successful completion of their Director’s training thanks to the support we receive from you, our Message alumni and friends”. On behalf of the School of Medicine taken from their publication, Rubor: Alumni Association and Alumni Relations Reflections on Medicine from the Wasatch office, I welcome the Class of 2017 Front. The magazine continues to explore into our alumni family. It was wonderful to participate how artistic expression allows students to reflect on their in their journey through medical school, starting with experiences in science and medicine (pages 18—20 and the stethoscope gift program at their White Coat cover art work). ceremony, through hosting the freshman class social with our School of Medicine Alumni Board members, This edition also depicts how training in hematology/ sponsoring Dinner with a Doc and HOST events (Help oncology at the U became a family affair for one Brazilian our Students Travel for fourth year students) through family, leading them to make a significant difference in their training years and encouraging them with healthy bone marrow transplantation progress in Brazil and the treats in the student lounge on test days. This year our United States. The magazine continues with highlights Student Emergency Fund saw more use than usual with from the 2015 School of Medicine book, How the almost $10,000 distributed to support medical students West Won Medicine, with this edition focusing on the who found themselves in serious financial straits due to pioneering work at the medical school occurring during unexpected illnesses or life events. With tuition and fees the 1980s. News Notebook features significant prizes for in-state students almost $40,000 this coming year, many awarded to current faculty and important research and students do not have any discretionary income to spare if an outreach occurring at the school. Of particular note is unexpected medical or family emergency arises. the article on research Thomas Lane, PhD is doing in the area of multiple sclerosis found on pages 26 and 27, We are only able to assist our students and encourage These Mice Are Walking: New discoveries in MS research. successful completion of their training thanks to the This is a topic near and dear to my own heart as I have support we receive from you, our alumni and friends. We ridden in the MS 150 bike ride for six years raising money are glad to be able to step up and not only help these to support Dr. Lane and other researchers searching for students financially, but make them feel they are part of a cure for MS. a larger family of University of Utah School of Medicine graduates who continue to care for current U students We are looking forward to the 2017 School of Medicine even after they have completed their own training and Alumni and Community Weekend on October 13—14 are out in practice. and hope many of you will join us, even if it isn’t your reunion year, to participate in some of the wonderful We were encouraged that many of our 2017 graduates want programming, such as the UTEMED talks and Alumni to pass along the generosity. Almost 100% of graduates Awards Banquet. We plan these activities to connect our going out of state for their residency training signed up for alumni from across the entire generational continuum to the HOST program to assist future fourth year students as learn from one another and stay involved with their alma they travel for residency interviews. A majority of students mater. Hope to see you there. show up every fall at our Thank-a-thon party to write thank you notes to their scholarship and stethoscope donors. They See you in October! are truly grateful for all the support and encouragement they receive from the School of Medicine Alumni Association as they progress through medical school.
Load more

Recommended publications
  • The Role of Viruses in the Cancerogenesis
    © 2014 by the author(s). This is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY-NC) licencse. Published by Poznan University of Medical Sciences REVIEW PAPER DOI: https://doi.org/10.20883/medical.e60 The role of viruses in the cancerogenesis Michał Chojnicki1, Mariola Pawlaczyk2, Celina Helak-Łapaj3, Jakub Żurawski1, Krzysztof Wiktorowicz1 1 Deptartment of Biology and Environmental Protection, Poznan University of Medical Sciences, Poland 2 Deptartment of Geriatric Medicine and Gerontology, Poznan University of Medical Sciences, Poland 3 Deptartment of Bioinformatics and Computational Biology, Chair of Pathology, Poznan University of Medical Sciences, Poland ABStrACt It is estimated that seven key viruses such as Hepatitis B virus (HBV), Hepatitis C virus (HCV), Human t-lymphotropic virus (HtLV), Human papilloma viruses (HPV), Kaposi’s sarcoma-associated herpes-virus (KSHV), Epstein-Barr virus (EBV) and Merkel cell polyomavirus (MCV), are responsible for about 11% of cancers all over the world. Viruses however are not only associated with cancerogenesis process. Scientific researches from recent years emphasize the possible use of the microorganisms as antitumor therapy. Oncoviruses, also defined as tumor viruses cause cancers whereas oncolytic viruses infect the host’s cancer cells leading to destruction of tumor and due to that they are described as cancer killing viruses. It offers the potential application of viral infections to the cancer therapy. Key words: cancers, cancerogensis, viruses. Early days na, held in 1824 in Verona, was the first documented A number of findings published within the past few suggestion of viral origins of the cancer. In his medical years have confirmed pathogens’ involvement in the practice, rigoni-Sterna learned that endometrial cancer aetiology of a significant share of human malignant was significantly more common in married women than cancers.
    [Show full text]
  • Oncogenic Viruses: a Potential CRISPR Treatment
    Oncogenic Viruses: A Potential CRISPR Treatment Neha Matai ∗ February 26, 2021 Abstract Oncogenic viruses promote carcinoma development by establishing long-term latent infections, obstructing tumor suppressor pathways, and transforming host cells into unchecked, proliferating malignancies. Epstein- Barr Virus, the first oncogenic virus to be discovered, can promote lym- phomagenesis in T cells, NK cells, and most commonly, resting memory B cells through the expression of oncoprotein LMP-1 and other proteins which may aid in B cell transformation. Human Papillomavirus is a com- mon infectious agent found in epithelial cells and has been shown to pro- mote malignant transformation in host cells through the overexpression of oncoproteins E6 and E7. Hepatitis C Virus, whose life cycle is not fully known yet, can also lead to carcinoma development in hepatocytes, and HCV oncoproteins NS3, NS4A, and NS5B have been associated with onco- genic roles. A novel genetic approach involving a CRISPR/Cas treatment designed to dysregulate these viral oncogenes can be used to combat these infections and their resulting carcinomas. While the long-term effects of CRISPR treatments are still being researched, this gene therapy offers a robust selection of potential treatments regarding long term diseases such as oncogenic viral infections. 1 Introduction The human population is prone to cancer through a wide variety of variables; in fact, 20% of which are caused by infectious agents such as bacteria, viruses, and other pathogens.1 Oncogenic viruses alone are responsible for 12% of all cancers diagnosed worldwide. More specifically, 80% of viral cancer cases occur in the developing world today.2 The first oncovirus was discovered in 1964 when researchers located the Epstein-Barr Virus in Burkitt’s Lymphoma cells using electron microscopy.3 Since this turning point in viral oncology, six more viruses have been confirmed to cause oncogenesis.
    [Show full text]
  • International Conference on Malignancies in HIV/AIDS
    th International Conference on 17 Malignancies in HIV/AIDS October 21-22, 2019 NIH Campus Bethesda, Maryland O˜ce of HIV and AIDS Malignancy | National Cancer Institute National Institutes of Health | U.S. Department of Health and Human Services PROGRAM Day 1: October 21 8:00 a.m. – 8:15 a.m. Day 1 Poster Setup Highlighted Posters (1-8) will stay up for the entire meeting. 8:15 a.m. – 8:20 a.m. Welcome and Introduction Robert Yarchoan, M.D. Director Office of HIV and AIDS Malignancy National Cancer Institute, NIH 8:20 a.m. – 8:30 a.m. Opening Remarks Douglas R. Lowy, M.D. Acting Director National Cancer Institute, NIH 8:30 a.m. – 8:35 a.m. Presentation of NCI Director’s Career Achievement Award to Drs. Patrick S. Moore and Yuan Chang 8:35 a.m. – 9:00 a.m. Plenary 1: 25 Years of KSHV Research Patrick S. Moore, M.D., M.P.H. University of Pittsburgh 9:00 a.m. – 10:00 a.m. Session 1: Kaposi’s Sarcoma-Associated Herpesvirus (KSHV) Moderators: Paul M. Lieberman, Ph.D. The Wistar Institute Thomas S. Uldrick, M.D., M.S. National Cancer Institute, NIH 9:00 a.m. – 9:15 a.m. O1. Functional Analysis of Human and Viral Circular RNAs During Kaposi’s Sarcoma Herpesvirus Infection Takanobu Tagawa, Ph.D. National Cancer Institute, NIH 9:15 a.m. – 9:30 a.m. O2. KSHV Manipulates Host Iron Metabolism and Antioxidant Pathways to Promote Tumorigenesis and Resist Ferroptotic Cell Death Ashlee V. Moses, Ph.D.
    [Show full text]
  • Merkel Cell Polyomavirus Small Tumor Antigen Activates
    bioRxiv preprint doi: https://doi.org/10.1101/2020.03.02.974303; this version posted March 4, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. 1 2 Title: Merkel Cell Polyomavirus Small Tumor Antigen Activates Matrix 3 Metallopeptidase-9 Gene Expression for Cell Migration and Invasion 4 5 Authors 6 Nnenna Nwogu1,3, Luz E. Ortiz1,3, Adrian Whitehouse2, Hyun Jin Kwun1,3,* 7 8 Affiliations 9 1Department of Microbiology and Immunology, Penn State University College of 10 Medicine, Hershey, PA, USA 11 12 2School of Molecular and Cellular Biology and Astbury Centre for Structural 13 Molecular Biology, Faculty of Biological Sciences, University of Leeds, Leeds, 14 United Kingdom. 15 16 3Penn State Cancer Institute, Hershey, PA, USA 17 18 19 *Correspondence: Hyun Jin Kwun 20 Department of Microbiology and Immunology, Penn State University College of 21 Medicine, Hershey, PA 17033, USA 22 E-mail addresses: [email protected] 23 Phone: (717) 512-7241 24 Fax: (717) 623-7715 25 26 27 28 Competing interests: The authors declare no competing interests. 29 30 31 32 Keywords: Merkel cell carcinoma, Merkel cell polyomavirus, small tumor antigen, Matrix 33 Metallopeptidase-9, FBW7, Cell migration, Cell invasion 34 35 36 37 38 39 40 41 42 43 44 45 bioRxiv preprint doi: https://doi.org/10.1101/2020.03.02.974303; this version posted March 4, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved.
    [Show full text]
  • Yuan Chang and Patrick Moore Win Prize for the Discovery of Two Cancer Viruses
    PAUL EHRLICH-STIFTUNG Chairman of the Scientific Council press release press release press release Frankfurt am Main, March 14, 2017 EMBARGO: March 14, 2017 - 2pm CET Paul Ehrlich and Ludwig Darmstaedter Prize 2017 awarded to Pitt Cancer Researchers Yuan Chang and Patrick Moore win prize for the discovery of two cancer viruses Scientists looking for new tumor viruses have to keep an eye out for the virus genes rather than the viral particles. This year's winners of the Paul Ehrlich and Ludwig Darmstaedter Prize were twice successful with this strategy. FRANKFURT am MAIN. Two Americans, Yuan Chang and Patrick S. Moore, will receive the 2017 Paul Ehrlich and Ludwig Darmstaedter Prize today in Frankfurt's Paulskirche for their discovery of the tumor viruses HHV-8 and MCV by means of a clever subtraction strategy. HHV-8 is the human herpesvirus 8, and MCV stands for Merkel cell polyomavirus. "With their decision to search for the viral genes rather than the viral particles, the prizewinners have taken a major step forward in the hunt for new human tumor viruses and have laid the foundation for further discoveries. The discovery of further human tumor viruses in future remains a distinct possibility," wrote the Scientific Council in substantiating its decision. One in every six cancers in the world is related to a viral infection However, the risk of cancer from a viral infection is lower in the Western industrial countries than in the developing world. Yuan Chang is Professor of Pathology at the University of Pittsburgh Cancer Institute. Patrick Moore is Professor and Director of the Cancer Virology Program at the University of Pittsburgh Cancer Institute.
    [Show full text]